VOLITIONRX LTD — Director's Dealing 2017

Sep 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-09-19

Reporting Person: Vanston David Cecil (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-19	COMMON STOCK	P	2750	$2.84	Acquired	2750	Direct